Imidazolidine-2,4-dione

Suppliers

Names

[ CAS No. ]:
461-72-3

[ Name ]:
Imidazolidine-2,4-dione

[Synonym ]:
Hydantoin
EINECS 207-313-3
Dantochlor
Glycolylurea
4H-Imidazole-2,5-diol
imidazolidinyl-2,4-dione
2,4-imidazolidindione
2,4-diketo-imidazolidine
2,4-Imidazolidinedione
imidazolidine-2,4-dione
2,4-dioxoimidazolidine
MFCD00005259
2,4-(3H,5H)-Imidazoledione

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Melting Point ]:
218-220 °C(lit.)

[ Molecular Formula ]:
C3H4N2O2

[ Molecular Weight ]:
100.076

[ Exact Mass ]:
100.027275

[ PSA ]:
58.20000

[ LogP ]:
-1.69

[ Vapour Pressure ]:
0.00448mmHg at 25°C

[ Index of Refraction ]:
1.476

[ Water Solubility ]:
SLIGHTLY SOLUBLE

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MT8210000
CHEMICAL NAME :
Hydantoin
CAS REGISTRY NUMBER :
461-72-3
BEILSTEIN REFERENCE NO. :
0110598
LAST UPDATED :
199701
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C3-H4-N2-O2
MOLECULAR WEIGHT :
100.09
WISWESSER LINE NOTATION :
T5MVM EVTJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
4140 mg/kg
SEX/DURATION :
female 1-39 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
CTOXAO Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. Volume(issue)/page/year: 18,1095,1981
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
14400 mg/kg
SEX/DURATION :
female 7-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - live birth index (measured after birth) Reproductive - Effects on Newborn - other neonatal measures or effects
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- Volume(issue)/page/year: 43,279,1991
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
12 gm/kg
SEX/DURATION :
female 11-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 64,271,1982
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
9 gm/kg
SEX/DURATION :
female 8-10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 64,271,1982
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
12 gm/kg
SEX/DURATION :
female 8-10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 64,271,1982
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
6 gm/kg
SEX/DURATION :
female 8-10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 64,271,1982 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5164 No. of Facilities: 7 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 28 (estimated)

Safety Information

[ Hazard Codes ]:
Xi

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S24/25

[ WGK Germany ]:
3

[ RTECS ]:
MT8210000

[ HS Code ]:
2933210000

Precursor & DownStream

Precursor

  • methyl 2-cyanamidoacetate
  • Urea
  • 1-Cyclohexylethan-1-one
  • 2-Thiohydantoin
  • Glycine
  • methyl 2-(hydroxymethoxy)acetate
  • Phenol
  • Malonamide
  • Glycine,N-(aminocarbonyl)-, ethyl ester

DownStream

  • 5-[(4-methylphenyl)methylidene]imidazolidine-2,4-dione
  • 2,4-IMIDAZOLIDINEDIONE, 1-BUTYL-
  • Glycine,N-(aminocarbonyl)-
  • 5-(2-methoxyphenyl)methylenehydantoin
  • Benzopinacole
  • 5-(hydroxydiphenylmethyl)-2,4-imidazolidinedione
  • 2,4-Imidazolidinedione,5-[(3,4,5-trimethoxyphenyl)methylene]-
  • 5-[(3-chlorophenyl)methylidene]imidazolidine-2,4-dione
  • DIETHYL 5-HYDANTOYLPHOSPHONATE
  • allantoin

Customs

[ HS Code ]: 2933210000

[ Summary ]:
2933210000 imidazolidine-2,4-dione。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。Lowest tariff:6.5%。General tariff:30.0%


Related Compounds

  • imidazolidine-2,4-dione
  • 1-nitro-imidazolidine-2,4-dione
  • 5-amino-imidazolidine-2,4-dione
  • 3-ethyl-imidazolidine-2,4-dione
  • 3-hexyl-imidazolidine-2,4-dione
  • 5-phenyl imidazolidine-2,4-dione
  • 2-(1-Isocyanatoethyl)-6,6-dimethylbicyclo[3.1.1]heptane
  • 4-methoxy-4-[(1-methyl-1H-pyrrol-2-yl)methyl]piperidine
  • 3,3,3-trifluoro-2-(1-methyl-2,3-dihydro-1H-indol-5-yl)propan-1-amine
  • 1-[(2R)-aziridine-2-carbonyl]-4-[(3-chlorophenyl)methyl]piperazine
  • rac-(1R,3R)-3-(furan-3-yl)-2,2-dimethylcyclopropan-1-amine
  • 3-(3,4-Dihydroxy-5-methoxyphenyl)-3-hydroxypropanenitrile
  • 2-[1-(2-Methoxyethyl)cyclopropyl]acetic acid
  • tert-butyl N-(6,6,6-trifluoro-2-methyl-5-oxohexan-3-yl)carbamate
  • 5-[1-(4-Bromophenyl)cyclopropyl]-1,3-oxazol-2-amine
  • 4-{1-[1-(2-methylpropyl)-1H-pyrazol-3-yl]ethyl}piperidine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.